Literature DB >> 19201838

TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal.

Blandine C Mercier1, Anne Cottalorda, Charles-Antoine Coupet, Jacqueline Marvel, Nathalie Bonnefoy-Bérard.   

Abstract

TLR are involved in the detection of microbial infection as well as endogenous ligands that signal tissue and cell damage in mammals. This recognition plays an essential role in innate immune response and the initiation of adaptive immune response. We have previously shown that murine CD8 T cells express TLR2, and that costimulation of Ag-activated CD8 T cells with TLR2 ligands enhances their proliferation, survival, and effector functions. We also demonstrated that TLR2 engagement on CD8 T cells significantly reduces their need for costimulatory signals delivered by APC. We show in this study that TLR2 engagement on CD8 T cells lowers the Ag concentration required for optimal activation, and converts a partial activation into a productive process leading to a significant expansion of cells. Using altered peptide ligands, we demonstrate that TLR2 engagement increases CD8 T cell activation and enables the generation of functional memory cells in response to a low TCR signal. This increased activation is associated with an augmented activation of the PI3K. Taken together, our results demonstrate that TLR2 engagement on CD8 T cells lowers their activation threshold for TCR signal strength and enables efficient memory cell generation in response to a weak TCR signal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201838     DOI: 10.4049/jimmunol.0801167

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

Review 1.  Modulation of immune responses through direct activation of Toll-like receptors to T cells.

Authors:  G Liu; L Zhang; Y Zhao
Journal:  Clin Exp Immunol       Date:  2010-01-29       Impact factor: 4.330

2.  Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function.

Authors:  Ahmad Faisal Karim; Scott M Reba; Qing Li; W Henry Boom; Roxana E Rojas
Journal:  Eur J Immunol       Date:  2017-07-18       Impact factor: 5.532

3.  Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease.

Authors:  Joseph M Reynolds; Bhanu P Pappu; Juan Peng; Gustavo J Martinez; Yongliang Zhang; Yeonseok Chung; Li Ma; Xuexian O Yang; Roza I Nurieva; Qiang Tian; Chen Dong
Journal:  Immunity       Date:  2010-04-29       Impact factor: 31.745

4.  Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells.

Authors:  Y Lai; J Weng; X Wei; L Qin; P Lai; R Zhao; Z Jiang; B Li; S Lin; S Wang; Q Wu; Z Tang; P Liu; D Pei; Y Yao; X Du; P Li
Journal:  Leukemia       Date:  2017-08-03       Impact factor: 11.528

5.  Different interleukin-17-secreting Toll-like receptor+ T-cell subsets are associated with disease activity in multiple sclerosis.

Authors:  Thais B Ferreira; Joana Hygino; Ana Cristina Wing; Taissa M Kasahara; Priscila M Sacramento; Solange Camargo; Fernanda Rueda; Soniza V Alves-Leon; Regina Alvarenga; Claudia Cristina Vasconcelos; Anshu Agrawal; Sudhir Gupta; Cleonice A M Bento
Journal:  Immunology       Date:  2017-12-26       Impact factor: 7.397

6.  Naive CD4+ T Cells Carrying a TLR2 Agonist Overcome TGF-β-Mediated Tumor Immune Evasion.

Authors:  Mohsen Ibrahim; Davide Scozzi; Kelsey A Toth; Donatella Ponti; Daniel Kreisel; Cecilia Menna; Elena De Falco; Antonio D'Andrilli; Erino A Rendina; Antonella Calogero; Alexander S Krupnick; Andrew E Gelman
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

7.  Direct TLR-2 Costimulation Unmasks the Proinflammatory Potential of Neonatal CD4+ T Cells.

Authors:  Brian D Sinnott; Byung Park; Mardi C Boer; Deborah A Lewinsohn; Christina L Lancioni
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

8.  Toll-Like Receptor 2 Recognizes Orientia tsutsugamushi and Increases Susceptibility to Murine Experimental Scrub Typhus.

Authors:  Mohammad Gharaibeh; Monica Hagedorn; Stefanie Lilla; Matthias Hauptmann; Holger Heine; Bernhard Fleischer; Christian Keller
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

Review 9.  TLR agonists: our best frenemy in cancer immunotherapy.

Authors:  Sabina Kaczanowska; Ann Mary Joseph; Eduardo Davila
Journal:  J Leukoc Biol       Date:  2013-03-08       Impact factor: 4.962

Review 10.  Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.

Authors:  Lidia Fernández-Paredes; Rebeca Pérez de Diego; Clara de Andrés; Silvia Sánchez-Ramón
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.